Press release
Global Central Nervous System (CNS) Therapeutics Market Size To Hit US$ 214.6 Billion by 2028 | IMARC Group
The central nervous system (CNS) represents a vital part of the nervous system that consists of the brain and the spinal cord. It incorporates the received information, thereafter, controlling and coordinating the activities of all aspects of the body. However, various CNS disorders, such as neurodegenerative diseases, autoimmune and inflammatory illnesses, genetic disorders, cancers, and others, affect the structure and function of the brain or spinal cord. Thus, CNS therapeutics are used to treat these disorders. These medications include sedatives, tranquilizers, and hypnotics that can slow brain activity, making them useful for treating panic, acute stress reactions, anxiety, and sleep disorders in individuals.
๐๐ผ๐๐ป๐น๐ผ๐ฎ๐ฑ ๐ ๐ฟ๐ฒ๐ฒ ๐๐ฎ๐บ๐ฝ๐น๐ฒ ๐๐ฟ๐ผ๐ฐ๐ต๐๐ฟ๐ฒ: https://www.imarcgroup.com/central-nervous-system-therapeutics-market/requestsample
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ง๐ญ๐ซ๐๐ฅ ๐๐๐ซ๐ฏ๐จ๐ฎ๐ฌ ๐๐ฒ๐ฌ๐ญ๐๐ฆ (๐๐๐) ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ
The rising approval of generic products, owing to patent expiration of essential medicines, such as Copaxone and Invega, has led to an expansion in treatment rate, especially in low- and middle-income countries, which is among the primary factors driving the central nervous system (CNS) therapeutics market. Besides this, the launch of several policies by the government bodies to boost the number of clinical trials and the introduction of innovative medications with improved efficacy, dosage, formulation, and aftereffects are further augmenting the market growth.
Moreover, the growing popularity of transdermal patches for central nervous system disorders that provide a precise amount of medicine and relief is also catalyzing the global market. Apart from this, the increasing advancements in the drug-delivery systems that have an edge over conventional methods, on account of the reduced adverse effects, are acting as significant growth-inducing factors. Furthermore, the elevating focus of the leading pharmaceutical players toward new therapies to prevent or enhance the symptoms of neurological disorders is expected to bolster the central nervous system (CNS) therapeutics market in the coming years.
๐๐ต๐ฒ๐ฐ๐ธ๐ผ๐๐ ๐ก๐ผ๐: https://www.imarcgroup.com/request?type=report&id=6114&flag=C
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ง๐ญ๐ซ๐๐ฅ ๐๐๐ซ๐ฏ๐จ๐ฎ๐ฌ ๐๐ฒ๐ฌ๐ญ๐๐ฆ (๐๐๐) ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ 2023-2028 ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The competitive landscape of the central nervous system (CNS) therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.
๐ฆ๐ผ๐บ๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ๐๐ฒ ๐ธ๐ฒ๐ ๐ฝ๐น๐ฎ๐๐ฒ๐ฟ๐ ๐ถ๐ป๐ฐ๐น๐๐ฑ๐ฒ:
AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
๐๐ฒ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป:
The report has segmented the central nervous system (CNS) therapeutics market bases on disease and application.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
The report has been segmented the market into following categories:
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐:
Neurodegenerative Diseases
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Huntington's Disease
Amyotrophic Lateral Sclerosis
Others
Neurovascular Diseases
CNS Trauma
Mental Health
Anxiety Disorders
Epilepsy
Mood Disorders
Psychotic Disorders
Others
Infectious Diseases
CNS Cancer
Others
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง:
Hospital
Clinic
Homecare
Others
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
๐๐๐ธ ๐๐ป๐ฎ๐น๐๐๐ ๐ณ๐ผ๐ฟ ๐ญ๐ฌ% ๐ณ๐ฟ๐ฒ๐ฒ ๐ฐ๐๐๐๐ผ๐บ๐ถ๐๐ฒ๐ฑ ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐: https://www.imarcgroup.com/central-nervous-system-therapeutics-market
๐๐ฒ๐ ๐๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐:
โข Market Performance (2017-2022)
โข Market Outlook (2023-2028)
โข Market Trends
โข Market Drivers and Success Factors
โข Impact of COVID-19
โข Value Chain Analysis
โข Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐ญ๐ก๐๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ-
Global Talc Market Report- https://www.openpr.com/news/2995621/talc-market-grow-at-cagr-of-4-6-during-2023-2028-imarc-group
Global eVTOL Aircraft Market Report- https://www.openpr.com/news/2962554/evtol-aircraft-market-worth-us-21-62-billion-by-2027-at-cagr
Global Medical Disposables Market Report- https://www.openpr.com/news/2961687/medical-disposables-market-worth-us-680-2-billion-by-2028
๐๐ผ๐ป๐๐ฎ๐ฐ๐ ๐จ๐ฆ:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 |
Europe & Africa: +44-753-713-2163 |
Asia: +91-120-433-0800
๐๐ฏ๐ผ๐๐ ๐จ๐:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Central Nervous System (CNS) Therapeutics Market Size To Hit US$ 214.6 Billion by 2028 | IMARC Group here
News-ID: 2995950 • Views: โฆ
More Releases from IMARC Group
Dental X-ray Market Research Report 2024-2032: Industry Growth, Share, Size and โฆ
IMARC Group's latest report, titled "Dental X-ray Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032", The global dental X-ray market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.
Dental X-rays are essential diagnostic tools that aid in visualizing the internal structures of the mouth, providing crucialโฆ
Diesel Generator Market Report 2024-2032: Growth, Sales, Revenue, Demand and For โฆ
IMARC Group's latest report, titled "Diesel Generator Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032", the global diesel generator market size reached US$ 17.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 31.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6.3% during 2024-2032.
A diesel generator is a reliable power generation device that combines a diesel engine with an electric generatorโฆ
Doors Market Size, Segment Analysis by Key Players, Growth Outlook, and Forecast โฆ
IMARC Group's latest research report, titled "Doors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," the global doors market size reached US$ 139.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 235.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.
Doors are fundamental architectural components that serve as entry and exit points in various building structures, ranging from residentialโฆ
Food Traceability Market Trends 2024, Leading Companies Share, Size and Forecast โฆ
IMARC Group's latest research report, titled "Food Traceability Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," the global food traceability market size reached US$ 20.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 41.4 Billion by 2032, exhibiting a growth rate (CAGR) of 8.3% during 2024-2032.
Request Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/food-traceability-market/requestsample
Food traceability refers to the ability to track andโฆ
More Releases for CNS
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The โฆ
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous systemโฆ
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo โฆ
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, andโฆ
CNS Therapeutics Technology Forecast Research Report 2018-2025
The Global CNS Therapeutics Market 2018-2028 report offers a detailed analysis of the industry, with market size forecasts covering the next ten years. This report will also analyze factors that influence demand for tactical communication, key market trends, and challenges faced by industry participants.
The CNS Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With theโฆ
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of theโฆ
Central Nervous System (CNS) Biomarkers Market - World is Witnessing a Rapid Gro โฆ
Biomarkers are used to indicate the biological state of a process, pathogenic process or therapeutic action. Biomarkers facilitate understanding the development of a chronic disease, relationship between exposure to environmental chemicals and identification of subgroups of people who are relatively at high risk of developing disease.
Download Exclusive Sample of this Report: http://bit.ly/2fOOwAv
Continued development in related technologies such as genomics, proteomics and imaging system has accelerated the development of biomarkers.โฆ
CNS Therapeutics Market Research Report 2016
โGlobal CNS Therapeutics Market Research Report 2016โ Order This Report by calling BigMarketResearch.com at +1-971-202-1575
Notes:
Production, means the output of CNS Therapeutics
Revenue, means the sales value of CNS Therapeutics
This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer, Inc. (USA)
Johnson & Johnson (USA)
Bristol-Myers Squibbโฆ
